Coronavirus vaccine could be ready by this time next year, says EU drugs agency
Official says he doubts one will be available by September
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.A coronavirus vaccine could be ready for approval in a year’s time in an “optimistic” scenario, the European Medicines Agency (EMA) has said.
The head of vaccines for the EMA – the body which approves medicines for the European Union – said he had doubts over claims one could be available by September.
Dr Marco Cavaleri said: “For vaccines, since the development has to start from scratch ... we might look from an optimistic side in a year from now, so beginning of 2021.”
More than 100 potential vaccines for Covid-19 are being worked on worldwide, with clinical trials under way for several of them.
Scientists at the University of Oxford started a human trial for their possible vaccine last month.
Results for this could available by June, according to an expert.
Professor Sir John Bell, regius professor of medicine at the University of Oxford, said “several hundred” people have been vaccinated in the trial.
The challenge now is to be able to manufacture at scale once it is approved by the regulators, he said.
As the world rushes to develop a vaccine, the EU – which includes some of the countries hardest hit by the virus – fears it may not have sufficient supplies, especially if a vaccine were developed in the US or China.
Mr Cavaleri said the EMA, in communication with more than 30 developers, was doing all it could to speed up the approval process. However, he said he was sceptical one would be ready in four months’ time.
He ruled out the possibility of skipping the third phase of a vaccine trial, which he said would be needed to be sure a vaccine is safe and effective.
A spokesperson for the World Health Organisation (WHO) warned earlier this week that coronaviruses are “very tricky viruses” which are “difficult to produce vaccines against”.
The health body – which is leading a global initiative to develop safe and effective vaccines, tests and treatments for Covid-19 – said in April that a coronavirus vaccine would take at least 12 months.
The EMA is also looking at 115 different therapeutics, or treatments, for the coronavirus, which has killed nearly 300,000 people globally.
Mr Cavaleri said some of those therapeutics could be approved in Europe as early as this summer, but he did not specify which.
More than 4.35 million people have tested positive for coronavirus in the world as of Thursday.
Additional reporting by agencies
Subscribe to Independent Premium to bookmark this article
Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments